TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Recipharm AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
705,541
|
595,436
|
247,874 |
Financial expenses |
6,529,997
|
3,428,349
|
1,637,762 |
Earnings before taxes |
-8,810,099
|
-21,087
|
78,809 |
EBITDA |
-306,495
|
-176,402
|
-248,631 |
Total assets |
22,947,164
|
29,509,387
|
17,368,210 |
Current assets |
13,017,009
|
3,974,858
|
2,496,485 |
Current liabilities |
4,399,448
|
2,114,465
|
1,663,025 |
Equity capital |
9,163,215
|
17,984,299
|
7,066,773 |
- share capital |
50,558
![]() |
50,558
![]() |
50,558 |
Employees (average) |
60
|
67
|
64 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
39.9%
|
60.9%
|
40.7% |
Turnover per employee |
11,759
|
8,887
|
3,873 |
Profit as a percentage of turnover |
-1248.7%
|
-3.5%
|
31.8% |
Return on assets (ROA) |
-9.9%
|
11.5%
|
9.9% |
Current ratio |
295.9%
|
188.0%
|
150.1% |
Return on equity (ROE) |
-96.1%
|
-0.1%
|
1.1% |
Change turnover |
110,105
|
347,562
|
-10,820,726 |
Change turnover % |
18%
|
140% | |
Chg. No. of employees |
-7
|
3
|
-7,793 |
Chg. No. of employees % |
-10%
|
5% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.